AstraZeneca PLC (AZN)
77.45
+0.41
(+0.53%)
USD |
NASDAQ |
May 15, 10:22
AstraZeneca Market Cap: 240.13B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 14, 2024 | 238.86B |
May 13, 2024 | 240.07B |
May 10, 2024 | 239.29B |
May 09, 2024 | 240.63B |
May 08, 2024 | 238.64B |
May 07, 2024 | 236.63B |
May 06, 2024 | 234.89B |
May 03, 2024 | 236.72B |
May 02, 2024 | 235.01B |
May 01, 2024 | 236.90B |
April 30, 2024 | 235.26B |
April 29, 2024 | 234.02B |
April 26, 2024 | 233.06B |
April 25, 2024 | 232.63B |
April 24, 2024 | 220.75B |
April 23, 2024 | 219.67B |
April 22, 2024 | 217.43B |
April 19, 2024 | 212.54B |
April 18, 2024 | 211.95B |
April 17, 2024 | 212.47B |
April 16, 2024 | 211.65B |
April 15, 2024 | 213.09B |
April 12, 2024 | 213.71B |
April 11, 2024 | 215.33B |
April 10, 2024 | 211.17B |
Date | Value |
---|---|
April 09, 2024 | 212.10B |
April 08, 2024 | 209.90B |
April 05, 2024 | 209.12B |
April 04, 2024 | 208.78B |
April 03, 2024 | 207.14B |
April 02, 2024 | 207.73B |
April 01, 2024 | 208.50B |
March 28, 2024 | 210.05B |
March 27, 2024 | 211.63B |
March 26, 2024 | 205.65B |
March 25, 2024 | 204.19B |
March 22, 2024 | 205.43B |
March 21, 2024 | 205.22B |
March 20, 2024 | 203.79B |
March 19, 2024 | 204.19B |
March 18, 2024 | 204.16B |
March 15, 2024 | 205.59B |
March 14, 2024 | 207.85B |
March 13, 2024 | 209.53B |
March 12, 2024 | 208.97B |
March 11, 2024 | 209.80B |
March 08, 2024 | 206.18B |
March 07, 2024 | 205.22B |
March 06, 2024 | 202.36B |
March 05, 2024 | 200.94B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
98.07B
Minimum
May 31 2019
240.63B
Maximum
May 09 2024
170.50B
Average
178.11B
Median
Market Cap Benchmarks
GSK PLC | 93.22B |
Amgen Inc | 168.76B |
Sanofi SA | 123.54B |
Viking Therapeutics Inc | 8.154B |
Fusion Pharmaceuticals Inc | 1.830B |
Market Cap Related Metrics
PE Ratio | 38.06 |
PS Ratio | 5.082 |
PEG Ratio | 1.095 |
Price to Book Value | 6.413 |
Price to Free Cash Flow | 41.82 |
Price | 77.45 |
Earnings Yield | 2.63% |
PEGY Ratio | 1.038 |
Operating PE Ratio | 25.39 |
Normalized PE Ratio | 34.83 |